CVKD Cadrenal Therapeutics, Inc. - Common Stock
$1,81
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 13, 2026
Rango 52S
$2–$15
0% of range
Calificación del Analista
BUY
8 analysts
Precio Objetivo
$14
+673% upside
P/E (TTM)
-0.3
ROE
-376.2%
Margen de Beneficio Neto
—
CVKD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.81
Capitalización Bursátil
$4M
P/E (TTM)
-0.3
BPA (TTM)
$-6.64
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-376.2%
Deuda/Capital
—
Rango 52S
$2 – $15
CVKD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-6.64
2022-12-31
→
2025-12-31
Flujo de caja libre
$-13M
2022-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
CVKD
Mediana de Pares
P/E (TTM)
-0.3
23.4
P/B (P/C)
1.5
1.2
Price / FCF (Precio / FCF)
-0.3
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
CVKD
Mediana de Pares
ROA
-183.2%
-98.4%
ROE
-376.2%
-129.3%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
CVKD
Mediana de Pares
Current Ratio (Ratio corriente)
2.7
3.2
Quick Ratio (Ratio Rápido)
2.5
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
CVKD
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
CVKD
Mediana de Pares
CVKD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
8 analistas
- Compra fuerte 2 25,0%
- Compra 5 62,5%
- Mantener 1 12,5%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
3 analistas · 2026-08-18
Mediana
$13.00
Media
$14.00
← Por Debajo de Todos los Objetivos
$1.81
Mín
$12.00
Máx
$17.00
Objetivo mediano
$13.00
+618,2%
Objetivo medio
$14.00
+673,5%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.17%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-1.04 | $-1.65 | 0.61% |
| 31 de diciembre de 2025 | $-1.43 | $-1.19 | -0.24% |
| 30 de septiembre de 2025 | $-1.31 | $-1.56 | 0.25% |
| 30 de junio de 2025 | $-1.87 | $-1.63 | -0.24% |
| 31 de marzo de 2025 | $-2.09 | $-1.67 | -0.42% |
| 31 de diciembre de 2024 | $-2.74 | $-1.75 | -0.99% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CVKD | $16M | -1.0 | — | — | -376.2% | — |
| PCSA | — | -0.3 | — | — | — | — |
| RVPH | $2M | — | — | — | -485.2% | — |
| SNES | $11M | -1.1 | 19.6% | -287.4% | -77.2% | 62.5% |
| CURX | $9M | -1.9 | — | — | -73.3% | — |
| SNOA | $4M | -1.1 | 36.7% | -16.3% | -92.3% | 38.0% |
| ENVB | $4M | -0.1 | -94.1% | 8275459.4% | -275.8% | — |
| PULM | $8M | -1.6 | 7.0% | — | -109.7% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cost of Revenue | · | · | $220.1K | · | |
| R&D Expense | $4M | $4M | $4M | $392.9K | |
| SG&A Expense | $9M | $7M | $4M | $2M | |
| Operating Expenses | $13M | $11M | $8M | $3M | |
| Operating Income | $-13M | $-11M | $-8M | $-3M | |
| Interest Expense | · | · | · | $40.2K | |
| Other Non-op | $223.8K | $309.3K | $-724.2K | $-4M | |
| Net Income | $-13M | $-11M | $-8M | $-7M | |
| EPS (Basic) | $-6.64 | $-8.73 | $-9.29 | $-0.85 | |
| EPS (Diluted) | $-6.64 | $-8.73 | $-9.29 | $-0.85 | |
| Shares (Basic) | 1,993,757 | 1,219,550 | 899,465 | 7,890,507 | |
| Shares (Diluted) | 1,993,757 | 1,219,550 | 899,465 | 7,890,507 | |
| EBITDA | $-13M | $-11M | $-8M | $-3M |
Balance general 18
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $10M | $8M | $32.6K | |
| Prepaid Expense | $200.1K | $42.3K | $52.4K | $22.7K | |
| Current Assets | $4M | $10M | $8M | $727.6K | |
| PP&E (Net) | $5.2K | $6.9K | $2.3K | $1.0K | |
| Other Non-current Assets | $2.2K | $3.8K | $3.8K | $6.0K | |
| Total Assets | $4M | $10M | $9M | $778.2K | |
| Accounts Payable | $650.7K | $2M | $167.3K | $404.9K | |
| Accrued Liabilities | $937.3K | $1M | $638.2K | $863.6K | |
| Short-term Debt | · | · | · | $43.7K | |
| Current Liabilities | $2M | $3M | $826.9K | $1M | |
| Capital Leases | · | · | · | $21.4K | |
| Total Liabilities | $2M | $3M | $826.9K | $6M | |
| Common Stock | $2.3K | $1.8K | $868 | $8.2K | |
| Paid-in Capital | $42M | $33M | $23M | $1M | |
| Retained Earnings | $-39M | $-26M | $-15M | $-7M | |
| Stockholders' Equity | $3M | $7M | $8M | $-6M | |
| Liabilities + Equity | $4M | $10M | $9M | $778.2K | |
| Shares Outstanding | 2,338,127 | 1,782,486 | 868,184 | 546,258 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $710.4K | $928.0K | |
| Operating Cash Flow | $-13M | $-7M | $-4M | $-1M | |
| CapEx | $5.1K | $6.5K | $3.3K | $2.3K | |
| Investing Cash Flow | $-5.1K | $-6.5K | $-3.3K | $-2.3K | |
| Stock Issued | $5M | $5M | · | $8.0K | |
| Net Stock Activity | $5M | $5M | · | $8.0K | |
| Financing Cash Flow | $7M | $9M | $12M | $1M | |
| Free Cash Flow | $-13M | $-7M | $-4M | $-1M |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -183.2% | -114.3% | -179.8% | -1725.7% | |
| ROE | -376.2% | -196.3% | -101.7% | 199.5% |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.7 | 3.8 | 10.3 | 0.5 | |
| Quick Ratio | 2.5 | 3.7 | 10.2 | · | |
| Interest Coverage | · | · | · | -67.2 |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-13M | $-11M | $-8M | $-7M | |
| Market Cap | $16M | $26M | $145M | · | |
| P/E | -1.0 | -1.7 | -1.2 | · | |
| P/B | 5.8 | 3.5 | 18.8 | · | |
| P / Tangible Book | 5.8 | 3.5 | 18.8 | · | |
| P / Cash Flow | -1.3 | -3.5 | -40.9 | · | |
| P / FCF | -1.3 | -3.5 | -40.9 | · | |
| Earnings Yield | -97.9% | -60.2% | -83.7% | · |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| R&D Expense | $705.2K | $771.5K | $666.3K | $688.5K | $1M | $2M | $2M | $784.6K | $1M | $629.0K | $361.1K | $243.9K | $241.0K | $3M | · | |
| SG&A Expense | $3M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $902.1K | $898.1K | $784.6K | $964.7K | $958.8K | |
| Operating Expenses | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $1M | $4M | $1M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | $-4M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.5K | · | |
| Other Non-op | $17.8K | $17.8K | $26.1K | $48.1K | $67.0K | $82.6K | $91.2K | $52.1K | $73.6K | $92.3K | $119.8K | $106.1K | $23.2K | $-973.3K | · | |
| Net Income | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | $-5M | $-5M | |
| EPS (Basic) | $-1.14 | $-1.04 | $-1.37 | $-1.31 | $-1.87 | $-2.09 | $-2.75 | $-2.18 | $-2.24 | $-1.56 | $-7.71 | $-1.01 | $-0.09 | $-0.48 | $-0.63 | |
| EPS (Diluted) | $-1.14 | $-1.04 | $-1.37 | $-1.31 | $-1.87 | $-2.09 | $-2.75 | $-2.18 | $-2.24 | $-1.56 | $-7.71 | $-1.01 | $-0.09 | $-0.48 | $-0.77 | |
| Shares (Basic) | 2,913,225 | 2,407,665 | -3,855,990 | 2,044,033 | 1,961,642 | 1,844,072 | -2,018,917 | 1,104,005 | 1,067,231 | 1,067,231 | -22,622,197 | 1,026,415 | 11,722,754 | 10,772,493 | -15,366,711 | |
| Shares (Diluted) | 2,913,225 | 2,407,665 | -3,855,990 | 2,044,033 | 1,961,642 | 1,844,072 | -2,018,917 | 1,104,005 | 1,067,231 | 1,067,231 | -22,622,197 | 1,026,415 | 11,722,754 | 10,772,493 | -15,366,711 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-4M | · | $-2M | $-2M | $-2M | · | $-1M | $-1M | $-4M | · |
Balance general 18
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $4M | $4M | $6M | $7M | $10M | $4M | $5M | $7M | · | $9M | · | · | $32.6K | |
| Prepaid Expense | $410.1K | $428.1K | $200.1K | $116.0K | $358.4K | $575.6K | $42.3K | $191.7K | $234.9K | $293.8K | $52.4K | $168.6K | $289.3K | $410.9K | $22.7K | |
| Current Assets | $6M | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $8M | $9M | $4M | $4M | $727.6K | |
| PP&E (Net) | $2.7K | $4.6K | $5.2K | $5.7K | $4.3K | $4.7K | $6.9K | $814 | $1.2K | $1.7K | $2.3K | $2.9K | $3.5K | $823 | $1.0K | |
| Other Non-current Assets | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $6.0K | |
| Total Assets | $6M | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $9M | $9M | $4M | $4M | $778.2K | |
| Accounts Payable | $871.9K | $824.8K | $650.7K | $614.1K | $895.6K | $1M | $2M | $496.8K | $759.5K | $400.4K | $167.3K | $141.7K | $78.1K | $119.6K | $404.9K | |
| Accrued Liabilities | $625.3K | $240.1K | $937.3K | $738.5K | $783.9K | $561.8K | $1M | $767.9K | $696.6K | $440.8K | $638.2K | $396.9K | $272.1K | $258.9K | $863.6K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $43.7K | |
| Current Liabilities | $1M | $1M | $2M | $1M | $2M | $2M | $3M | $1M | $1M | $856.3K | $826.9K | $563.6K | $374.3K | $401.6K | $1M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $2.2K | $8.8K | $15.2K | $21.4K | |
| Total Liabilities | $1M | $1M | $2M | $1M | $2M | $2M | $3M | $1M | $1M | $856.3K | $826.9K | $565.8K | $383.1K | $416.8K | $6M | |
| Common Stock | $3.1K | $2.5K | $2.3K | $2.1K | $2.0K | $1.9K | $1.8K | $1.2K | $16.0K | $16.0K | $868 | $13.0K | $11.7K | $11.7K | $8.2K | |
| Paid-in Capital | $49M | $43M | $42M | $39M | $38M | $36M | $33M | $25M | · | · | $23M | $23M | $16M | $16M | · | |
| Retained Earnings | $-45M | $-41M | $-39M | $-36M | $-33M | $-30M | $-26M | $-22M | $-19M | $-17M | $-15M | $-14M | $-13M | $-12M | $-7M | |
| Stockholders' Equity | $4M | $2M | $3M | $3M | $4M | $6M | $7M | $3M | $4M | $6M | $8M | $9M | $3M | $4M | $-6M | |
| Liabilities + Equity | $6M | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $9M | $9M | $4M | $4M | $778.2K | |
| Shares Outstanding | 3,098,592 | 2,506,817 | 2,338,127 | 2,059,754 | 2,007,113 | 1,909,732 | 1,782,486 | 1,234,672 | 16,008,469 | 16,008,469 | 868,184 | 13,022,754 | 11,722,754 | 11,722,754 | 8,193,875 |
Flujo de Efectivo 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $672.1K | $252.4K | $325.1K | $473.4K | $592.6K | $548.8K | $763.2K | $300.0K | $193.1K | $162.7K | $103.1K | $153.1K | $167.8K | $286.4K | · | |
| Operating Cash Flow | $-2M | $-3M | $-3M | $-2M | $-3M | $-5M | $-2M | $-2M | $-2M | $-2M | $-694.4K | $-627.8K | $-795.3K | $-1M | · | |
| CapEx | · | · | $0 | $1.9K | $0 | $3.3K | · | · | · | · | $0 | $1 | · | · | · | |
| Investing Cash Flow | · | · | $0 | $-1.9K | $0 | $-3.3K | · | · | · | · | $0 | $-1 | · | · | · | |
| Stock Issued | $2M | $-64.0K | $846.1K | $668.0K | $1M | $-85.3K | $4M | · | · | · | · | · | $0 | $5M | · | |
| Net Stock Activity | · | $-64.0K | · | · | · | $2M | · | · | · | · | · | · | · | $5M | · | |
| Financing Cash Flow | $2M | $1M | $3M | $648.4K | $1M | $2M | $7M | $2M | $0 | $298 | $-12.5K | $7M | $0 | $5M | · | |
| Free Cash Flow | · | · | · | · | · | $-5M | · | · | · | · | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -57.5% | -46.2% | · | -61.3% | -64.1% | -51.3% | · | -34.4% | -53.1% | -28.8% | · | -22.3% | -56.4% | -230.9% | · | |
| ROE | -79.2% | -63.1% | · | -87.4% | -88.5% | -62.5% | · | -39.6% | -66.8% | -32.4% | · | -23.7% | -63.2% | -254.5% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 2.7 | · | 3.0 | 3.6 | 4.3 | · | 3.7 | 3.7 | 8.2 | · | 16.5 | 9.4 | 11.1 | · | |
| Quick Ratio | 1.6 | 2.2 | · | 2.9 | 3.3 | 4.0 | · | 3.4 | 3.4 | 7.7 | · | 16.2 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -1188.5 | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-13M | · | $-13M | $-12M | $-10M | · | $-8M | $-6M | $-9M | · | $-8M | $-8M | $-7M | · | |
| Market Cap | $10M | $13M | · | $28M | $24M | $34M | · | $17M | $113M | $146M | · | $133M | $266M | $248M | · | |
| P/E | -0.6 | -0.8 | · | -1.9 | -1.4 | -2.2 | · | -2.0 | -1.4 | -2.9 | · | -6.0 | -36.0 | -37.8 | · | |
| P/B | 2.5 | 7.1 | · | 10.4 | 5.6 | 5.5 | · | 4.9 | 28.3 | 23.7 | · | 15.2 | 83.6 | 61.0 | · | |
| P / Tangible Book | 2.5 | 7.1 | · | 10.4 | 5.6 | 5.5 | · | 4.9 | 28.3 | 23.7 | · | 15.2 | 83.6 | 61.0 | · | |
| P / Cash Flow | · | -4.3 | · | · | · | -7.2 | · | · | · | -79.8 | · | · | · | -175.5 | · | |
| P / FCF | · | · | · | · | · | -7.2 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -160.5% | -123.2% | · | -53.9% | -69.5% | -45.8% | · | -51.2% | -69.5% | -34.3% | · | -16.8% | -2.8% | -2.6% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Beneficio neto | $-13M | $-11M | $-8M | $-7M |
| EPS Diluido | $-6.64 | $-8.73 | $-9.29 | $-0.85 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Ratio corriente | 2.7 | 3.8 | 10.3 | 0.5 |
| Ratio Rápido | 2.5 | 3.7 | 10.2 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Flujo de caja libre | $-13M | $-7M | $-4M | $-1M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 22 declarantes · $332K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 9 (+5 vs trimestre anterior) | 6 (+3 vs trimestre anterior) | 2 (+1 vs trimestre anterior) | 2 (-3 vs trimestre anterior) | +82K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $167 458 | 50 137 | 50,38% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $59 806 | 17 906 | 17,99% | Acciones |
| VANGUARD GROUP INC | $59 061 | 8 711 | 17,77% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $27 759 | 8 311 | 8,35% | Acciones |
| CoreCap Advisors, LLC | $4 292 | 1 285 | 1,29% | Acciones |
| Tower Research Capital LLC (TRC) | $4 282 | 1 282 | 1,29% | Acciones |
| Grove Bank & Trust | $3 340 | 1 000 | 1,00% | Acciones |
| Clearstead Advisors, LLC | $2 171 | 650 | 0,65% | Acciones |
| Quest 10 Wealth Builders, Inc. | $1 269 | 380 | 0,38% | Acciones |
| OSAIC HOLDINGS, INC. | $1 002 | 300 | 0,30% | Acciones |
| Rockefeller Capital Management L.P. | $501 | 150 | 0,15% | Acciones |
| WELLS FARGO & COMPANY/MN | $331 | 99 | 0,10% | Acciones |
| BARCLAYS PLC | $311 | 93 | 0,09% | Acciones |
| Integrated Wealth Concepts LLC | $287 | 86 | 0,09% | Acciones |
| Archer Investment Corp | $117 | 35 | 0,04% | Acciones |
| IFP Advisors, Inc | $100 | 30 | 0,03% | Acciones |
| HRT FINANCIAL LP | $97 | 29 055 | 0,03% | Acciones |
| UBS Group AG | $90 | 27 | 0,03% | Acciones |
| Farther Finance Advisors, LLC | $84 | 25 | 0,03% | Acciones |
| CALDWELL SUTTER CAPITAL, INC. | $17 | 5 | 0,01% | Acciones |
| Cygnus Capital Advisors, LLC | $8 | 1 492 | 0,00% | Acciones |
| MORGAN STANLEY | $7 | 2 | 0,00% | Acciones |
Informantes de la empresa 10 insiders · 5 directivos · 6 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Quang X. Pham | Chairman and CEO | 29 de junio de 2026 S | 98 589 | 0 | 33 | $-700 645 |
| Matthew K Szot | Chief Financial Officer | 29 de diciembre de 2025 S | 0 | 0 | 12 | $-397 433 |
| Jeffrey Scott Cole | Chief Operating Officer | 23 de enero de 2025 A | — | 0 | 0 | $0 |
| James J. Ferguson III | Chief Medical Officer | 5 de febrero de 2025 A | — | 0 | 0 | $0 |
| Douglas W Losordo | Chief Medical Officer | 18 de enero de 2024 A | — | 0 | 0 | $0 |
| Lee Scott Golden | Consejero | 2 de diciembre de 2025 A | — | 0 | 0 | $0 |
| Robert Lisicki | Consejero | 23 de enero de 2025 A | — | 0 | 0 | $0 |
| Steven Zelenkofske | Consejero | 23 de enero de 2025 A | — | 0 | 0 | $0 |
| Glynn Wilson | Consejero | 23 de enero de 2025 A | 50 000 | 0 | 0 | $0 |
| John Raymond Murphy | Consejero | 23 de enero de 2025 A | 614 792 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Quang X. Pham, The PVBQ Living Trust | 29 de enero de 2025 | 23,60% | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.